| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.081 | 0.1 |